Stock THC TENET HEALTHCARE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Tenet Healthcare Corporation

Equities

THC

US88033G4073

Healthcare Facilities & Services

Market Closed - Nyse
Other stock markets
 01:30:01 27/04/2024 am IST 		5-day change 1st Jan Change
96.13 USD -1.42% Intraday chart for Tenet Healthcare Corporation +3.15% +27.21%
26/04 HCA beats first-quarter profit estimates on higher patient admissions RE
19/04 Tenet Healthcare, union coalition reach tentative deal RE

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 3,951 4,213 8,751 5,275 7,674 9,535 - -
Enterprise Value (EV) 1 18,440 17,486 22,033 19,496 21,448 20,941 20,722 20,354
P/E ratio -17 x 10.6 x 9.7 x 12.9 x 13.2 x 6.58 x 15.5 x 13.9 x
Yield - - - - - - - -
Capitalization / Revenue 0.21 x 0.24 x 0.45 x 0.28 x 0.37 x 0.47 x 0.45 x 0.43 x
EV / Revenue 1 x 0.99 x 1.13 x 1.02 x 1.04 x 1.03 x 0.97 x 0.91 x
EV / EBITDA 6.81 x 5.56 x 6.33 x 5.62 x 6.06 x 6.16 x 5.77 x 5.31 x
EV / FCF 32.8 x 6.1 x 24.2 x 60.7 x 13.2 x 10.2 x 12.2 x 13.6 x
FCF Yield 3.05% 16.4% 4.13% 1.65% 7.57% 9.81% 8.23% 7.36%
Price to Book -10.7 x 151 x 8.52 x 2.03 x 2.42 x 2.59 x 2.17 x 1.82 x
Nbr of stocks (in thousands) 1,03,895 1,05,517 1,07,126 1,08,123 1,01,552 99,186 - -
Reference price 2 38.03 39.93 81.69 48.79 75.57 96.13 96.13 96.13
Announcement Date 24/02/20 09/02/21 07/02/22 09/02/23 08/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 18,479 17,640 19,485 19,174 20,548 20,332 21,256 22,385
EBITDA 1 2,706 3,146 3,483 3,469 3,541 3,399 3,589 3,831
EBIT 1 1,856 2,289 2,628 2,628 2,671 2,561 2,734 3,011
Operating Margin 10.04% 12.98% 13.49% 13.71% 13% 12.6% 12.86% 13.45%
Earnings before Tax (EBT) 1 296 671 1,888 1,344 1,617 2,463 1,721 1,809
Net income 1 -232 399 914 411 611 2,170 601.6 727
Net margin -1.26% 2.26% 4.69% 2.14% 2.97% 10.67% 2.83% 3.25%
EPS 2 -2.240 3.750 8.420 3.790 5.710 14.60 6.194 6.932
Free Cash Flow 1 563 2,867 910 321 1,623 2,055 1,705 1,498
FCF margin 3.05% 16.25% 4.67% 1.67% 7.9% 10.11% 8.02% 6.69%
FCF Conversion (EBITDA) 20.81% 91.13% 26.13% 9.25% 45.83% 60.46% 47.5% 39.11%
FCF Conversion (Net income) - 718.55% 99.56% 78.1% 265.63% 94.72% 283.41% 206.05%
Dividend per Share 2 - - - - - - - -
Announcement Date 24/02/20 09/02/21 07/02/22 09/02/23 08/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 4,894 4,856 4,745 4,638 4,801 4,990 5,021 5,082 5,066 5,379 5,155 4,978 4,955 5,217 5,191
EBITDA 1 855 1,017 888 843 841 897 832 843 854 1,012 828 817.7 819.2 939.5 867.1
EBIT 1 646 816 685 627 632 684 615 630 630 796 618.5 612.5 609.3 722.9 662.9
Operating Margin 13.2% 16.8% 14.44% 13.52% 13.16% 13.71% 12.25% 12.4% 12.44% 14.8% 12% 12.3% 12.3% 13.86% 12.77%
Earnings before Tax (EBT) 1 774 528 378 265 380 321 380 373 345 519 392 395 407.7 502.3 427
Net income 1 448 249 140 38 131 102 143 123 101 244 1,822 137.3 136 209 163
Net margin 9.15% 5.13% 2.95% 0.82% 2.73% 2.04% 2.85% 2.42% 1.99% 4.54% 35.36% 2.76% 2.74% 4.01% 3.14%
EPS 2 4.120 2.290 1.280 0.3500 1.160 0.9200 1.320 1.150 0.9400 2.300 7.846 1.344 1.360 1.876 1.628
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 20/10/21 07/02/22 20/04/22 21/07/22 20/10/22 09/02/23 25/04/23 31/07/23 30/10/23 08/02/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 14,489 13,273 13,282 14,221 13,774 11,406 11,188 10,819
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 5.354 x 4.219 x 3.813 x 4.099 x 3.89 x 3.356 x 3.117 x 2.824 x
Free Cash Flow 1 563 2,867 910 321 1,623 2,055 1,705 1,498
ROE (net income / shareholders' equity) 6.98% 31.5% 173% 68.6% 44.4% 24.5% 17.4% 19.7%
ROA (Net income/ Total Assets) 1.23% 3.34% 3.34% 2.72% 2.2% 3.85% 2.2% 2.58%
Assets 1 -18,891 11,958 27,342 15,118 27,734 56,410 27,382 28,165
Book Value Per Share 2 -3.560 0.2600 9.590 24.00 31.20 37.10 44.30 52.70
Cash Flow per Share 2 11.90 32.10 14.40 9.800 22.70 18.70 17.70 18.80
Capex 1 670 540 658 762 751 812 825 859
Capex / Sales 3.63% 3.06% 3.38% 3.97% 3.65% 3.99% 3.88% 3.84%
Announcement Date 24/02/20 09/02/21 07/02/22 09/02/23 08/02/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Tenet Healthcare Corporation

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
96.13 USD
Average target price
111.7 USD
Spread / Average Target
+16.24%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+27.21% 9.53B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
DAVITA INC. Stock DaVita Inc.
+27.44% 11.71B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. THC Stock
  4. Financials Tenet Healthcare Corporation